Medical devices, healthcare technology and the business of care
510(k) clearance · K260180

Carecube Negative Pressure Isolation Chamber (1BY)

Carecubes, Inc. · Decision date Oct 16, 2026

MEDTECHLEDGER EXPLANATIONK260180

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision for the Carecube Negative Pressure Isolation Chamber (1BY), submitted by Carecubes, Inc. of San Francisco, California, under 510(k) number K260180. The device falls under the classification name Chamber, Patient Isolation, regulation number 880.5450, product code LGM, with General Hospital as the regulation medical specialty and review panel. The application was a Traditional 510(k) received on 01/21/2026, with the decision dated 10/16/2026.

SESE in this 510(k) context indicates clearance to market, not premarket approval. The record shows the review was not conducted by a third party, was not a combination product, and had no authorized Predetermined Change Control Plan. The public page does not include the predicate device, the summary of similarities and differences, or any performance data, so the specific basis for the equivalence determination remains unknown from this source.

Regulatory pathway
510(k) premarket notification
Clinical specialty
General Hospital
Decision date
Oct 16, 2026
FDA decision documents: 510(k) Premarket Notification - FDA

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K260180
Regulatory pathway
510(k) premarket notification
Product code
LGM
Decision code
SESE
Decision date
Oct 16, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Chamber, Patient Isolation.

Product code
LGM
FDA device class
2

FDA decision timeline

  1. K260180 received

    Application receipt date recorded by FDA.

  2. K260180 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

No additional submissions with a verified PMA or product-code relationship are linked here.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Carecubes, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
San Francisco, CA

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records